Skip to main content

Advertisement

Table 2 Adverse events according to MedDRA SOC by study group

From: Safety of the methylene blue plus chloroquine combination in the treatment of uncomplicated falciparum malaria in young children of Burkina Faso [ISRCTN27290841]

  CQ (N = 45) CQ-MB (N = 181)
Gastrointestinal disorders 23 (38.3%) 93 (41.5%)
Respiratory disorders 16 (26.7%) 78 (34.8%)
Infections and infestations 10 (16.7%) 38 (17.0%)
Skin and subcutaneous tissue disorders 8 (13.3%) a 9 (4.0%) a
Others 3 (5.1%) 6 (2.7%)
  1. a p = 0.017